quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:22:25·44d
SECFiling
Exagen Inc. logo

SEC Form 10-K filed by Exagen Inc.

XGN· Exagen Inc.
Health Care
Original source

Companies

  • XGN
    Exagen Inc.
    Health Care

Recent analyst ratings

  • Sep 11UpdateB. Riley Securities$15.00
  • Jul 30UpdateKeyBanc Capital Markets$12.00
  • Jul 23UpdateCraig Hallum$12.00
  • Aug 5UpdateKeyBanc Capital Markets-
  • Nov 11UpdateKeybanc$30.00
  • Oct 15UpdateCowen$26.00

Related

  • SEC13h
    Exagen Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
  • INSIDER2d
    Amendment: SEC Form 3 filed by new insider Mckhann Chas
  • INSIDER38d
    New insider Mckhann Chas claimed ownership of 7,500 units of Restricted Stock Units (SEC Form 3)
  • INSIDER38d
    Chief Financial Officer Black Jeffrey G. was granted 76,511 shares, increasing direct ownership by 29% to 343,953 units (SEC Form 4)
  • INSIDER38d
    President and CEO Aballi John was granted 150,000 shares, increasing direct ownership by 22% to 839,834 units (SEC Form 4)
  • SEC44d
    Exagen Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • PR44d
    Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results
  • INSIDER50d
    President and CEO Aballi John sold $56,827 worth of shares (15,698 units at $3.62) and was granted 2,535 shares, decreasing direct ownership by 2% to 689,834 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022